Mounjaro alternatives over the counter: what you can and can't buy without a prescription

The shelves don't hold what you're really after

You're probably here because Mounjaro sounds promising, costs a fair amount, and you're wondering if there's a simpler route. That's a completely reasonable place to land. The frustrating truth is that the biology behind tirzepatide (activating both GIP and GLP-1 receptors to reduce appetite and slow gastric emptying) cannot be replicated by any capsule or powder that bypasses a prescriber. The how Mounjaro works page goes deeper on the mechanism, but the short version is that these are injectable peptides acting on specific gut-hormone receptors. Nothing in a health-food shop does that.

Low-dose orlistat (Alli, 60mg) is the only product sold over the counter in the UK that holds any formal weight-management claim. It works by blocking roughly a third of dietary fat from being absorbed, a different mechanism entirely, with more modest average results. Higher-dose orlistat (120mg, prescription-only) is somewhat more effective, but still falls well short of the weight reductions seen in tirzepatide trials. The NHS orlistat page sets out honestly what it can and cannot do.

Then there is a sprawling market of supplements: berberine, green tea extract, glucomannan fibre, chromium, garcinia cambogia. Some have a modest evidence base for blood-sugar or lipid markers in small studies. None has been tested head-to-head against a licensed GLP-1 medicine in a large, independent clinical trial. If you want a clear picture of what does and doesn't stand up as a Mounjaro alternative, it's worth reading through the evidence before spending money on any of them. They are not regulated as medicines by the MHRA; they are food supplements, held to a different standard entirely. That is worth sitting with before spending money on them.

What a prescription actually gives you that an over-the-counter product cannot

A prescription for Mounjaro is not a bureaucratic hurdle. It is the output of a clinical assessment that checks whether the medicine is likely to help you and unlikely to harm you. A trained prescriber reviews your weight, BMI, medical history, any conditions that would make GLP-1 treatment unsuitable (certain GI conditions, a history of pancreatitis, specific thyroid conditions), and any medicines you already take. That review catches things a supplement seller never sees.

The why Mounjaro isn't sold over the counter page covers the regulatory reasons in detail, but the practical upshot is straightforward: skipping that assessment does not just mean breaking a rule, it means missing a safety net. Counterfeit pens sold without a prescription have caused hospitalisations, some containing insulin rather than tirzepatide. The MHRA has seized large quantities of fake weight-loss pens from unregulated online sellers, and enforcement has escalated significantly since 2023. If a seller offers Mounjaro or anything marketed to do the same job, without asking for a prescription, that is a red flag worth taking seriously.

At nume, every consultation is read by a GPhC-registered Independent Prescriber, a real clinician, not a screening algorithm. If you're eligible, the prescription is issued the same day. If you're not, you'll be told why, which is also useful information.

Tablets, without needles, the closest legitimate option for some people

If part of the appeal of an over-the-counter search is avoiding injections, it is worth knowing that an oral GLP-1 medicine now exists in the UK. The MHRA approved Wegovy tablets (oral semaglutide) in June 2026, the first oral GLP-1 licensed for weight management in the UK. It still requires a prescription. But for people who want a daily tablet rather than a weekly injection, it is a legitimate clinical route. You can read more about it alongside the injectable options on the treatment overview page.

If you're specifically curious about tablet-based alternatives to Mounjaro, our guide to tablet alternatives sets out what is and isn't licensed. The picture is more interesting than it was twelve months ago, but the prescription requirement holds across all of them. A quick look at the cost context is also useful if price is part of what's driving the search, the private market has moved considerably since Eli Lilly's list-price changes in autumn 2025, and understanding what a legitimate price includes (consultation, prescription, clinical review, aftercare) is the best lens for comparing options.

If Mounjaro isn't the right fit, what the clinical alternatives actually are

Not everyone who looks for an over-the-counter alternative is trying to avoid the prescription process, some people have been told Mounjaro isn't suitable for them and want to know what else exists. That is a different question, and a fairer one. The licensed alternatives within the GLP-1 class are semaglutide-based: Wegovy (injection) and Wegovy tablets. Both require the same kind of clinical assessment. Our weight-loss alternatives guide covers the evidence behind each, including the SURMOUNT-5 head-to-head data comparing tirzepatide and semaglutide published in the New England Journal of Medicine in 2025.

For a broader look at what the evidence says, NICE's appraisal of tirzepatide (TA1026) sets out clearly which adults the clinical evidence supports treating, and on what basis. If you fall into that group and want to explore the private route, a free consultation with our prescribers is the practical next step. Check your eligibility at the consultation page, it takes a few minutes and, if it's not the right fit, you'll know that quickly too.